Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Metachronous Mucinous Breast Carcinoma and Mucinous Pancreatic Cystadenoma in a Patient With Metabolic Comorbidities- Case Report and Minireview

Version 1 : Received: 23 August 2023 / Approved: 23 August 2023 / Online: 23 August 2023 (11:22:36 CEST)

How to cite: Alexescu, T.; Obada, I.; Cozma, A.; Alb, M.; Orăsan, O.H.; Negrean, V.; Domsa, I.; Tarmure, S.F. Metachronous Mucinous Breast Carcinoma and Mucinous Pancreatic Cystadenoma in a Patient With Metabolic Comorbidities- Case Report and Minireview. Preprints 2023, 2023081657. https://doi.org/10.20944/preprints202308.1657.v1 Alexescu, T.; Obada, I.; Cozma, A.; Alb, M.; Orăsan, O.H.; Negrean, V.; Domsa, I.; Tarmure, S.F. Metachronous Mucinous Breast Carcinoma and Mucinous Pancreatic Cystadenoma in a Patient With Metabolic Comorbidities- Case Report and Minireview. Preprints 2023, 2023081657. https://doi.org/10.20944/preprints202308.1657.v1

Abstract

Mucinous breast carcinoma is a rare subtype of mammary neoplasm encountered in medical practice. It represents approximately 1-6% of all breast cancers and is more common in postmenopausal women. There are two subtypes of mucinous breast carcinoma: pure and mixed. We report the case of a 73-year-old Caucasian woman diagnosed with mucinous pancreatic cystadenoma in 2007. She underwent a surgical procedure involving pancreatectomy of the body and tail, along with multiple known cardiovascular and metabolic comorbidities. In November 2019, during a clinical-biological evaluation for associated diseases, a mucinous carcinoma of the right breast was accidentally detected and later confirmed through further investigations. For treatment, a surgical procedure was performed involving lower right quadrantectomy with right axillary lymph node dissection. The postoperative clinical course was favorable. In conclusion, we present the case of a patient diagnosed with mixed mucinous breast carcinoma, without axillary lymph node invasion. Postmenopausal women with diabetes, overweight, and obesity have an increased susceptibility to breast cancer, with our patient having all these risk factors. To date, no study has demonstrated the genetic or radiation implication in the occurrence of mucinous carcinomas, nor the possible development of mucinous carcinomas in series in the same patient. Current data are insufficient to provide recommendations for the screening of malignant mucinous tumors in subjects with significant cardiometabolic risk factors.

Keywords

Mucinous breast carcinoma; pancreatic cancer; diabetes mellitus type 2; obesity; metabolic syndrome; postmenopausal women

Subject

Medicine and Pharmacology, Internal Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.